期刊文献+

肝移植术后巨细胞病毒性肺炎并呼吸窘迫综合征的早期诊断和处理 被引量:1

Early diagnosis and management of acute respiratory distress syndrome caused by cytomegalovirus pneumonia after liver transplantation
原文传递
导出
摘要 目的探讨肝移植术后巨细胞病毒性肺炎合并呼吸窘迫综合征的早期诊断和处理。方法回顾性分析2001年4月至2004年5月期间8例肝移植患者术后出现巨细胞病毒性肺炎合并呼吸窘迫综合征的临床资料。8例患者均给予更昔洛韦5mg/kg静脉滴注,2次/d;减少他克莫司(FK506)或环孢素A(CsA)1/3~1/2的用量,停用霉酚酸酯(MMF)和泼尼松;使用呼吸机辅助呼吸,同时加强支持治疗。结果8例患者中5例痊愈,3例死亡。无1例发生急性排斥反应。结论胸部X线、CT检查及临床表现是早期诊断的关键。抗巨细胞病毒治疗、调整免疫抑制剂用量、使用呼吸机辅助呼吸及有效的营养支持均是改善肝移植术后巨细胞病毒性肺炎合并呼吸窘迫综合征的有力措施。 Objective To study the early diagnosis and management of the patients with acute respiratory distress syndrome (ARDS) caused by cytomegalovirus (CMV) pneumonia after liver transplantation. Methods The clinical data of 8 patients with ARDS caused by CMV pneumonia after liver transplantation in our hospital from April 2001 to May 2004 was retrospectively analyzed. All cases were treated with intravenous infusion of gancyclovir, reduced dosage of cyclosporine A or tacrolimus to 1/3~1/2 of baseline and withdrawal of MMF and prednisone. The patients were subjected to breathing machine assist ventilation and nutrition supply. Results Five patients recovered and 3 died. No one developed acute rejection. Conclusions The key of early diagnosis lies in combining chest X-ray or CT scan with clinical presentation. Administration with anti-viral drugs, adjustment of immunosuppressive agents, management with breathing machine assist ventilation and effective nutrition supply are important for the treatment of patients with ARDS caused by CMV pneumonia after liver transplantation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第10期581-583,共3页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献6

  • 1Post AB, Mulligan DC, Bush W. Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients. Transplantation, 1998, 66: 2102-2103.
  • 2Benita ZW, Kerstin C, Eriksson BM, et al. Cytomegalovirusplasma(CMV) DNA amplification from compared with CMV pp65 antigen (pRUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.Clin Diagnostic Virology, 1996, 7:99-110.
  • 3Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver trensplantation. Hepatology, 1993, 18:185-195.
  • 4Nina S, Cheryl W, Lois K, et al. Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation, 2004, 77:106-110.
  • 5Castellvi JM, Xiol X, Guardiola J, et al. Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status. Transpl Int, 2004, 17:131-137.
  • 6VanderBerg AP, Vanson WJ, Janssen RA, et al. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J Infect Dis, 1992, 166:1228-1235.

同被引文献4

  • 1Shimon K, Rafael M. Infectious complications [M].In: Shapiro R, Simmons RL, Starzl T E, eds. Renal transplantation. Stanford: Appleton & Lange, 1997.315-332.
  • 2Connelly K G, Repine J E. Markers for predicting the development of acute respiratory distress syndrome[J].Ann Rev Med, 1997,48:429-445.
  • 3Chastre J, Fagon J Y, Lamer C H. Procedures for the diagnosis of pneumonia in ICU patients[J]. Intensive Care Med, 1992,18:S10-S17.
  • 4Jordi R, Jordi V. Hospital-acpuired pneumonia in the ICU patients[J]. Semi Respir Crit Care Med,1997,18:133-140.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部